PERSPECTA

News from every angle

Back to headlines

Barclays Initiates AbbVie with Overweight Rating on Growth Potential

Barclays has assigned an 'Overweight' rating to AbbVie (ABBV), citing the pharmaceutical company's significant growth potential.

23 Feb, 18:13 — 23 Feb, 18:13
PostShare

Sources

Showing 1 of 1 sources